---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-036358"
form_type: "8-K"
ticker: "STAA"
cik: "0000718937"
company_name: "STAAR SURGICAL CO"
filed_at: "2022-11-02T23:59:59+00:00"
generated_at: "2026-06-22T15:56:46.896709+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# STAAR Surgical Q3 net sales $76M (+30% YoY); ICL units +40%; guides FY22 ~$285M

## Summary
- Net sales $76.0M, constant currency $80.0M (+37%); ICL sales $72.0M (+33%), ICL units +40%.
- GAAP EPS $0.21, adjusted EPS $0.37 vs. $0.12 and $0.21 in prior year quarter.
- Gross margin 79.5% vs 77.6%; operating expenses $46.8M vs $37.5M.
- FY22 net sales guided to ~$285M (~$300M constant currency); ICL sales ~$272M (+28% YoY).
- Other Products to be phased out by end-2023; FY23 net sales target ~$355M with 30% ICL growth.

## SEC filing metadata
- accession: 0001564590-22-036358
- form_type: 8-K
- ticker: STAA
- cik: 0000718937
- company_name: STAAR SURGICAL CO
- filed_at: 2022-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/718937/000156459022036358/0001564590-22-036358-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/718937/000156459022036358/staa-8k_20221102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-036358
- JSON: https://secwatch.observer/filing/0001564590-22-036358.json
- Plain text: https://secwatch.observer/filing/0001564590-22-036358.txt

## Key facts
- Earnings Releases
  STAAR SURGICAL CO reported the third quarter ended September 30, 2022 results: revenue $76.0 million, net income $10.3 million or $0.21 per diluted share, EPS $0.21 per diluted share. Guidance reaffirmed.
  - Period: the third quarter ended September 30, 2022
  - Revenue: $76.0 million
  - Net income: $10.3 million or $0.21 per diluted share
  - EPS: $0.21 per diluted share
  - Guidance: reaffirmed
  - Result: reported results
  source text: STAAR Surgical Reports Third Quarter Net Sales of $76 Million Up 30% Y/Y
  evidence_url: https://www.sec.gov/Archives/edgar/data/718937/000156459022036358/0001564590-22-036358-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.